面部疼痛的干预管理:一个回顾性的案例系列
Ramya Lakkaraju1, Jason E Crowther1, Pascal Scemama1
1University of Massachusetts Medical School, Worcester, MA.
Pain medicine case reports
|July 3, 2025
概括
神经阻塞为慢性面部疼痛患者提供显著的疼痛缓解,这些患者对药物无反应. 超声波引导的手术在三个月内平均减少了80%的疼痛,尽管可能需要重复治疗.
科学领域:
- 神经学 神经学
- 疼痛医学 医学 疼痛医学
- 干预性疼痛管理 干预性疼痛管理
背景情况:
- 慢性面部疼痛通常需要先进的治疗,当保守措施失败时.
- 非典型的三角神经 presents一个挑战,有效的疼痛管理.
- 对于不耐火的面部疼痛病例,可以考虑进行干预程序.
研究的目的:
- 为了评估神经阻塞对非典型三角神经疼痛患者的疗效.
- 在接受神经阻塞的患者中评估疼痛缓解和反应持续时间.
- 探索超声波引导的神经阻塞作为慢性面部疼痛的治疗选择.
主要方法:
- 分析了20名患有非典型三角神经疼痛的患者的病例系列.
- 由于医疗管理导致疼痛缓解不足的患者经历了神经阻塞.
- 程序包括基于疼痛分布的内轨道,上轨道,上关,带关或三角神经块.
主要成果:
- 患者在3个月的时间内平均经历了80%的疼痛改善.
- 疼痛缓解的有效性和持续时间因患者而异.
- 超声波引导的神经阻塞显示出显著的缓解疼痛的潜力.
结论:
- 像神经阻塞这样的干预技术是面部疼痛管理的可行选择.
- 超声导向的神经阻塞为耐药患者提供了显著的缓解.
- 对于持续的疼痛管理,可能需要重复神经阻塞程序.
相关概念视频
Analgesia and Pain Management
3.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Pericarditis III: Medical Management
586
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
586
Angina IV: Management
493
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493


